Rheumatology
Cohort Study | Cutaneous involvement in catastrophic antiphospholipid syndrome.
8 Dec, 2022 | 12:53h | UTCCutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients – JAMA Dermatology (free for a limited period)
Commentary on Twitter
In this cohort study, half of patients with catastrophic APS (CAPS) showed cutaneous involvement, with a spectrum of clinical presentations, including distal inflammatory edema. Skin biopsies confirmed diagnosis in all but 1 biopsied patient. https://t.co/lwBL3lyLxT
— JAMA Dermatology (@JAMADerm) December 7, 2022
RCT | Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment.
7 Dec, 2022 | 14:29h | UTC
Brief Review | Management of pericarditis in rheumatic diseases.
7 Dec, 2022 | 14:16h | UTCManagement of Pericarditis in Rheumatic Diseases – American College of Cardiology
Case Report | Vitamin D intoxication and severe hypercalcemia complicating nutritional supplements misuse.
6 Dec, 2022 | 13:56h | UTCCommentaries:
Vitamin D supplement ‘overdosing’ is possible and harmful, warn doctors – Medical Dialogues
How an increasingly popular supplement landed a man in the hospital – CNN
You Can Take Too Much Vitamin D — One Man Found Out the Hard Way – HealthDay
Guideline | Lateral elbow pain and muscle function impairments.
5 Dec, 2022 | 00:15h | UTC
M-A | Thiazide diuretics and fracture risk.
29 Nov, 2022 | 14:23h | UTC
Podcast | Back pain update.
29 Nov, 2022 | 14:07h | UTC#368 Back Pain Update with
Dr. Austin Baraki – The Curbsiders
RCT | Remotely delivered cognitive behavioral and personalized exercise interventions for fatigue severity and impact in rheumatic diseases.
29 Nov, 2022 | 13:46h | UTC
SR | Yoga for chronic non‐specific low back pain.
27 Nov, 2022 | 22:08h | UTCYoga for chronic non‐specific low back pain – Cochrane Library
Summary: Yoga for chronic non-specific low back pain – Cochrane Library
Commentaries:
Is yoga good for back pain? Here’s the evidence – Evidently Cochrane
RCT | Vitamin D fails to prevent statin-associated muscle symptoms among new statin users.
25 Nov, 2022 | 12:40h | UTCStatin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo – JAMA Cardiology (free for a limited period)
Commentary: Vitamin D fails to reduce statin-associated muscle pain – Northwestern University
Commentary on Twitter
Vitamin D supplementation did not prevent statin-associated muscle symptoms or reduce statin discontinuation among new statin users in the randomized VITAL trial. https://t.co/wNZoeJ8PZf
— JAMA Cardiology (@JAMACardio) November 23, 2022
SR | Strategies to prevent and manage running-related knee injuries.
25 Nov, 2022 | 12:37h | UTCStrategies to prevent and manage running-related knee injuries: a systematic review of randomised controlled trials – British Journal of Sports Medicine (link to abstract – $ for full-text)
Commentaries:
How can we prevent and manage running-related knee injuries? – BJSM Blog
Commentary from the author on Twitter
?️Infographic summarising the findings of our recently published Systematic Review in @BJSM_BMJ .
Abstract and full text found here…?https://t.co/vKALOWkbc6 pic.twitter.com/XfOWsySqt0
— James Alexander (@JamesA_15) October 16, 2022
RT | Routine early arthroscopic partial meniscectomy is not superior to physical therapy for traumatic meniscal tears.
25 Nov, 2022 | 12:38h | UTC
Commentary on Twitter
⚠️ Traumatic meniscal tears ?
✨Arthroscopic partial meniscectomy vs physical therapy✨
Which management is more optimal for improving symptoms, knee function and ability to participate in sports ⁉️?
NEW #OpenAccess Original Research ?
➡️ https://t.co/Z0FSuRboj7 pic.twitter.com/aBgjcxfCav
— British Journal of Sports Medicine (BJSM) (@BJSM_BMJ) June 15, 2022
SR | Adjunctive therapies in addition to land‐based exercise therapy for osteoarthritis of the hip or knee.
23 Nov, 2022 | 13:40h | UTC
Commentary on Twitter
New Cochrane Review ??
? "Compared with land-based exercise therapy, additional therapies plus exercise therapy, may not be more effective in improving pain, physical function, quality of life or joint changes."https://t.co/AU2LuyTwg8 pic.twitter.com/k2HYBMpJXp
— Physio Meets Science (@PhysioMeScience) October 17, 2022
Phase 2b RCT | Rituximab vs. IV cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease.
17 Nov, 2022 | 12:24h | UTCCommentaries:
RECITAL: Rituximab represents alternative to cyclophosphamide for CTD-ILD – medwire News
CTD-ILD: Rituximab ‘a Reasonable Alternative to Cyclophosphamide’ – Medscape (free registration required)
Commentary on Twitter
https://twitter.com/LancetRespirMed/status/1592057243075112960
Phase 2 RCT | Efficacy and safety of low-dose Interleukin 2 for primary Sjögren syndrome.
17 Nov, 2022 | 12:20h | UTCCommentary: Sjogren’s Responds to Cytokine Treatment, Early Data Show — Phase II trial signals possible breakthrough for hard-to-treat illness – MedPage Today (free registration required)
RCT | In patients with end-stage ankle osteoarthritis, total ankle replacement and arthrodesis resulted in comparable results.
16 Nov, 2022 | 13:45h | UTCTotal Ankle Replacement Versus Arthrodesis for End-Stage Ankle Osteoarthritis: A Randomized Controlled Trial – Annals of Internal Medicine (link to abstract – $ for full-text)
News Release: Trial shows benefits of two forms of ankle surgery for osteoarthritis – University College London
Summary for Patients: Total Ankle Replacement Versus Arthrodesis for End-Stage Ankle Osteoarthritis
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in rheumatic diseases.
15 Nov, 2022 | 12:55h | UTC
Commentary on Twitter
https://twitter.com/ARD_BMJ/status/1590254371257946112
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological DMARDs.
15 Nov, 2022 | 12:53h | UTCCommentary: Updated EULAR recommendations on the use of DMARDs for people with RA – News Medical
RCT | Genicular nerve block offers short-term pain relief in patients with knee osteoarthritis.
15 Nov, 2022 | 12:50h | UTCCommentary: Genicular nerve block may provide short-term pain relief for knee osteoarthritis – medwire News
Matched cohort study | Long-term clinical and radiographic outcomes in patients with clinically isolated aortitis.
11 Nov, 2022 | 13:43h | UTC
M-A | Cardiovascular safety of febuxostat and allopurinol in patients with gout.
11 Nov, 2022 | 13:41h | UTC
Cohort Study | Study shows subclinical Hyperthyroidism is linked to an increased risk of fractures.
10 Nov, 2022 | 14:08h | UTCAssociation Between Subclinical Thyroid Dysfunction and Fracture Risk – JAMA Network Open
Commentary: Does Subclinical Hyperthyroidism Raise Fracture Risk? – Medscape (free registration required)
Commentary on Twitter
Subclinical hyperthyroidism may be an independent risk factor associated with fracture, highlighting a potential role for more aggressive screening and monitoring to prevent bone mineral disease. #OAReasearch https://t.co/LQVjaNU1zM
— JAMA Network Open (@JAMANetworkOpen) November 8, 2022
Cohort Study | Systemic lupus erythematosus low disease activity and mortality risk.
10 Nov, 2022 | 13:48h | UTCLupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study – The Lancet Rheumatology (link to abstract – $ for full-text)
Commentary on Twitter
NEW RESEARCH—Lupus low disease activity state (#LLDAS) significantly reduced the risk of mortality in patients with #SLE; remission did not further reduce the risk of mortality unless lower glucocorticoid thresholds were used https://t.co/xYqzQME3li #LupusAwarenessMonth pic.twitter.com/gtLTKn92Go
— The Lancet Rheumatology (@TheLancetRheum) October 24, 2022
M-A | DOACs increase the risk of arterial thrombosis vs. Vitamin-K antagonists in antiphospholipid syndrome.
9 Nov, 2022 | 12:28h | UTCDirect Oral Anticoagulants vs Vitamin-K Antagonists in Thrombotic Antiphospholipid Syndrome: Meta-analysis of Randomized Controlled Trials – Journal of the American College of Cardiology (link to abstract – $ for full-text)
SR | Efficacy and safety of IL-6 inhibition with biological DMARDs in immune-mediated inflammatory diseases.
8 Nov, 2022 | 11:47h | UTC
Commentary on Twitter
Check out our latest systematic literature review on IL-6 inhibition in immune-mediated inflammatory diseases:
▶️ positive clinical in a group of diseases
▶️ benefits in #COVID-19
▶️ similar safety outcomes vs other bDMARDs? https://t.co/N1S9H2NrLQ pic.twitter.com/IAFGoEgkrY
— ARD & RMD Open (@ARD_BMJ) September 29, 2022